CAL 131
Latest Information Update: 05 Sep 2007
At a glance
- Originator Chong Kun Dang
- Class Antibacterials
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 03 Aug 1998 No-Development-Reported for Bacterial infections in South Korea (Unknown route)
- 09 Jun 1995 New profile